Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
about
Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.Metabolomics and Metabolic Reprogramming in Kidney Cancer.High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma.Translating Metabolic Reprogramming into New Targets for Kidney CancerHyperpolarized C magnetic resonance imaging, using metabolic imaging to improve the detection and management of prostate, bladder, and kidney urologic malignancies
P2860
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
@en
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
@nl
type
label
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
@en
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
@nl
prefLabel
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
@en
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
@nl
P2093
P2860
P356
P1433
P1476
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer
@en
P2093
Aaron L Sarver
Ashley Graef
Benjamin Stewart
Ching-Hsien Chen
Francisco Uzal
Grace Berryhill
Hiromi Wettersten
Jeffrey Kim
Josephine F Trott
Omran Abu Aboud
P2860
P304
66540-66557
P356
10.18632/ONCOTARGET.11658
P407
P577
2016-10-01T00:00:00Z